Cidara Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Cidara Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • Cidara Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $11.5M, a 4.59% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.5M +$505K +4.59% Dec 31, 2023 10-K 2024-04-22
Q4 2022 $11M -$13M -54.1% Dec 31, 2022 10-K 2024-04-22
Q4 2021 $24M +$655K +2.81% Dec 31, 2021 10-K 2024-04-22
Q4 2020 $23.3M +$777K +3.44% Dec 31, 2020 10-K 2023-03-23
Q4 2019 $22.6M +$6.03M +36.5% Dec 31, 2019 10-K 2023-03-23
Q4 2018 $16.5M +$5.77M +53.6% Dec 31, 2018 10-K 2022-03-07
Q4 2017 $10.8M +$6.11M +132% Dec 31, 2017 10-K 2021-02-25
Q4 2016 $4.64M +$4.29M +1204% Dec 31, 2016 10-K 2020-03-04
Q4 2015 $356K +$248K +230% Dec 31, 2015 10-K 2019-02-28
Q4 2014 $108K +$102K Dec 31, 2014 10-K 2018-02-27
Q4 2013 $6K* +$6K Dec 31, 2013 10-K 2017-03-15
Q4 2012 $0 Dec 31, 2012 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.